KB

Kubendran Balaiya Pillai

Director Director DIN 00139230
DIN 00139230 First appointment Sep 2002 Primary industry Travel and Hospitality
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Sep 2002
Shareholding value •••• Premium profile

About Kubendran Balaiya Pillai

Data last updated:

Kubendran Balaiya Pillai was a Director at Zurich Bio-Tech Pharma Limited (2002–2011) and Director at Holy Remedies Private Limited (2005–2009). The companies operate in Travel and Hospitality and Chemicals.

DIN 00139230
Primary Designation Director
Industry Travel and Hospitality
First Appointment 02 Sep 2002

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Zurich Bio-Tech Pharma Limited U55101TN1996PLC035913
Director02 Sep 20021996Strike Off
Holy Remedies Private Limited U24232TN2005PTC057703
Director29 Sep 20052005Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Zurich Bio-Tech Pharma Limited
Holy Remedies Private Limited
Premium access

Shareholding and investment profile for Kubendran Balaiya Pillai

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kubendran Balaiya Pillai

Kubendran Balaiya Pillai was first appointed on 02 Sep 2002 as Director at Zurich Bio-Tech Pharma Limited. The most recent appointment on record is 29 Sep 2005 at Holy Remedies Private Limited.

Kubendran Balaiya Pillai held 2 earlier board appointments: Zurich Bio-Tech Pharma Limited (Director, 02 Sep 2002 to 30 Mar 2011); Holy Remedies Private Limited (Director, 29 Sep 2005 to 01 Apr 2009).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available